Chelsea Therapeutics.

PositionCharlotte - Brief article

CHARLOTTE -- Chelsea Therapeutics is in the middle of second-stage clinical testing on a drug to treat rheumatoid arthritis. The three-month test of CH-1504 is scheduled to end in April. Chelsea believes its drug is as effective as existing treatments and has fewer side effects.

For a...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT